Literature DB >> 12734899

Clinical and radiological changes during psoriatic arthritis disease progression.

Mustafa Khan1, Catherine Schentag, Dafna D Gladman.   

Abstract

OBJECTIVE: To determine the contribution of radiological findings at the initial visit with respect to classifying patients with psoriatic arthritis (PsA); and to determine the extent to which the clinical disease patterns change over time.
METHODS: Patients with PsA were followed prospectively at 6-12 month intervals since 1978; 86 patients were registered within 1 year of diagnosis and were followed for at least 1 year. Based on the clinical information, including the actively inflamed joint count, damaged joint count, and the presence of back disease and arthritis mutilans, a clinical PsA pattern was assigned. A separate radiology pattern based on radiographs alone, and a combined clinical and radiological pattern, was also assigned at each visit. The initial clinical pattern was compared to the initial combined clinical-radiological pattern, and the initial clinical pattern was compared to the clinical pattern at 1 year and 5 years in 35 patients with both 1 and 5 year followup.
RESULTS: In 23% of the patients, the radiological assessment in the initial visit showed evidence of patterns not detected clinically; 49% and 77% of the patients showed clinical pattern change within 1 year and 5 years, respectively. A comparison between the group that changed pattern and the one that did not change pattern in 5 years revealed no significant features.
CONCLUSION: Radiological assessments add information not gained from clinical assessment alone. Clinical patterns do change over time in the majority of patients. Both elements must be taken into consideration when developing classification criteria for PsA.

Entities:  

Mesh:

Year:  2003        PMID: 12734899

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

2.  Classification and categorisation of psoriatic arthritis.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2008-07-16       Impact factor: 2.980

Review 3.  Psoriatic arthritis: phenotypic variance and nosology.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

4.  Is remission a more realistic goal in psoriatic arthritis?

Authors:  Tajvur P Saber; Ursula Fearon; Douglas J Veale
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 5.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

6.  Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel.

Authors:  Devy Zisman; Lihi Eder; Muna Elias; Arie Laor; Haim Bitterman; Michael Rozenbaum; Joy Feld; Doron Rimar; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

7.  Evaluation of spinal mobility measurements in predicting axial psoriatic arthritis.

Authors:  Ying-ying Leung; Kwok Wah Ho; Lai Shan Tam; Tracy Y Zhu; Lai W Kwok; Tena K Li; Emily W Kun; Edmund K Li
Journal:  Clin Rheumatol       Date:  2011-03-03       Impact factor: 2.980

8.  [Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

9.  Remission in psoriatic arthritis.

Authors:  Kurt de Vlam; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 10.  Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease.

Authors:  Helena Iznardo; Lluís Puig
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.